Skip to main content
. 2022 Mar 30;22(5):535–544. doi: 10.1007/s40256-022-00525-w

Fig. 1.

Fig. 1

Echocardiographic outcome of patients after sacubitril/valsartan presented with significantly lower moderate or severe valvular insufficiency at follow-up; p values for the comparison between follow-up time and month 0